Work

Figure S2 from Preclinical Evaluation of B7-H3–specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia

Year: 2023

Type: other

Abstract: B7-H3 expression is retained on THP1 cells and patient-derived AML blasts after B7-H3.CAR-T treatment

DOI: 10.1158/1078-0432.22479035

Authors: Eben I. Lichtman, Hongwei Du, Peishun Shou, Feifei Song, Kyogo Suzuki, Sarah Ahn, Guangming Li, Soldano Ferrone, Lishan Su, Barbara Savoldo, Gianpietro Dotti

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362414116

Cites:

Cited by:

Related to: 10